Hard to Treat Diseases, Inc. (HTDS)

0.0000 0.00 (0.00%) USD  |  OTCM  |  Feb 20, 16:00
More

Hard to Treat Diseases EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for HTDS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Plus Therapeutics, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
Nutriband, Inc. Upgrade
Immunovant, Inc. Upgrade
Definium Therapeutics, Inc. Upgrade